» Articles » PMID: 34381107

Decidualized Endometrial Stromal Cells Present with Altered Androgen Response in PCOS

Overview
Journal Sci Rep
Specialty Science
Date 2021 Aug 12
PMID 34381107
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperandrogenic women with PCOS show disrupted decidualization (DE) and placentation. Dihydrotestosterone (DHT) is reported to enhance DE in non-PCOS endometrial stromal cells (eSC); however, this has not been assessed in PCOS cells (eSC). Therefore, we studied the transcriptome profile of non-decidualized (non-DE) and DE eSCs from women with PCOS and Ctrl in response to short-term estradiol (E2) and/or progesterone (P4) exposure with/without (±) DHT. The non-DE eSCs were subjected to E2 ± DHT treatment, whereas the DE (0.5 mM 8-Br-cAMP, 96 h) eSCs were post-treated with E2 and P4 ± DHT, and RNA-sequenced. Validation was performed by immunofluorescence and immunohistochemistry. The results showed that, regardless of treatment, the PCOS and Ctrl samples clustered separately. The comparison of DE vs. non-DE eSC without DHT revealed PCOS-specific differentially expressed genes (DEGs) involved in mitochondrial function and progesterone signaling. When further adding DHT, we detected altered responses for lysophosphatidic acid (LPA), inflammation, and androgen signaling. Overall, the results highlight an underlying defect in decidualized eSC, present with or without DHT exposure, and possibly linked to the altered pregnancy outcomes. We also report novel factors which elucidate the mechanisms of endometrial dysfunction in PCOS.

Citing Articles

The hidden impact of GLP-1 receptor agonists on endometrial receptivity and implantation.

Sola-Leyva A, Pathare A, Apostolov A, Aleksejeva E, Kask K, Tammiste T Acta Obstet Gynecol Scand. 2024; 104(2):258-266.

PMID: 39696822 PMC: 11782050. DOI: 10.1111/aogs.15010.


Stanniocalcin Protein Expression in Female Reproductive Organs: Literature Review and Public Cancer Database Analysis.

Khatun M, Modhukur V, Piltonen T, Tapanainen J, Salumets A Endocrinology. 2024; 165(10).

PMID: 39186548 PMC: 11398916. DOI: 10.1210/endocr/bqae110.


Dysregulated RNA editing of EIF2AK2 in polycystic ovary syndrome: clinical relevance and functional implications.

Kong F, Feng J, Yao J, Lu Y, Guo T, Sun M BMC Med. 2024; 22(1):229.

PMID: 38853264 PMC: 11163819. DOI: 10.1186/s12916-024-03434-8.


Polycystic ovary syndrome.

Stener-Victorin E, Teede H, Norman R, Legro R, Goodarzi M, Dokras A Nat Rev Dis Primers. 2024; 10(1):27.

PMID: 38637590 DOI: 10.1038/s41572-024-00511-3.


Hyperinsulinemia impairs decidualization via AKT-NR4A1 signaling: new insight into polycystic ovary syndrome (PCOS)-related infertility.

Jiang N, Zhao W, Shen H, Du D, Li X J Ovarian Res. 2024; 17(1):31.

PMID: 38310251 PMC: 10837998. DOI: 10.1186/s13048-023-01334-8.


References
1.
Sheng X, Yung Y, Chen A, Chun J . Lysophosphatidic acid signalling in development. Development. 2015; 142(8):1390-5. PMC: 4392601. DOI: 10.1242/dev.121723. View

2.
Garcia-Herrero S, Meseguer M, Martinez-Conejero J, Remohi J, Pellicer A, Garrido N . The transcriptome of spermatozoa used in homologous intrauterine insemination varies considerably between samples that achieve pregnancy and those that do not. Fertil Steril. 2009; 94(4):1360-1373. DOI: 10.1016/j.fertnstert.2009.07.1671. View

3.
Hulchiy M, Nybacka A, Sahlin L, Linden Hirschberg A . Endometrial Expression of Estrogen Receptors and the Androgen Receptor in Women With Polycystic Ovary Syndrome: A Lifestyle Intervention Study. J Clin Endocrinol Metab. 2015; 101(2):561-71. DOI: 10.1210/jc.2015-3803. View

4.
Hu M, Li J, Zhang Y, Li X, Brannstrom M, Shao L . Endometrial progesterone receptor isoforms in women with polycystic ovary syndrome. Am J Transl Res. 2018; 10(8):2696-2705. PMC: 6129510. View

5.
Palomba S, Piltonen T, Giudice L . Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2020; 27(3):584-618. DOI: 10.1093/humupd/dmaa051. View